JP2013537414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537414A5 JP2013537414A5 JP2013523260A JP2013523260A JP2013537414A5 JP 2013537414 A5 JP2013537414 A5 JP 2013537414A5 JP 2013523260 A JP2013523260 A JP 2013523260A JP 2013523260 A JP2013523260 A JP 2013523260A JP 2013537414 A5 JP2013537414 A5 JP 2013537414A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- isolated
- binding agent
- chain polypeptide
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37097810P | 2010-08-05 | 2010-08-05 | |
| US61/370,978 | 2010-08-05 | ||
| PCT/US2011/046201 WO2012018767A2 (en) | 2010-08-05 | 2011-08-02 | Antibodies directed against il-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013537414A JP2013537414A (ja) | 2013-10-03 |
| JP2013537414A5 true JP2013537414A5 (enExample) | 2014-09-18 |
Family
ID=45560018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013523260A Pending JP2013537414A (ja) | 2010-08-05 | 2011-08-02 | Ｉｌ−１７に対する抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9328166B2 (enExample) |
| EP (1) | EP2601217B1 (enExample) |
| JP (1) | JP2013537414A (enExample) |
| CN (1) | CN103154026B (enExample) |
| AU (1) | AU2011285922B2 (enExample) |
| BR (1) | BR112013002831A2 (enExample) |
| ES (1) | ES2633145T3 (enExample) |
| NZ (1) | NZ607615A (enExample) |
| RU (1) | RU2595385C2 (enExample) |
| WO (1) | WO2012018767A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2577228C2 (ru) * | 2014-03-14 | 2016-03-10 | Закрытое Акционерное Общество "Биокад" | Анти-il-17-антитела, способ их получения и способ применения |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| CN108251431B (zh) * | 2015-03-05 | 2020-12-08 | 北京百特美博生物科技有限公司 | 双载体系统及其用途 |
| CN109053884A (zh) * | 2015-11-02 | 2018-12-21 | 东南大学 | Wasabi蛋白纳米抗体及其编码序列与应用 |
| CN107236041B (zh) * | 2016-03-29 | 2020-07-24 | 舒泰神（北京）生物制药股份有限公司 | Il-17抗体 |
| CN107488227A (zh) * | 2016-06-12 | 2017-12-19 | 三生国健药业（上海）股份有限公司 | 抗人白细胞介素‑17a单克隆抗体、其制备方法和应用 |
| US11619832B2 (en) | 2018-03-08 | 2023-04-04 | Coopervision International Limited | Identification of contact lens wearers predisposed to contact lens discomfort |
| EP3689907A1 (en) | 2019-01-31 | 2020-08-05 | Numab Therapeutics AG | Antibodies targeting il-17a and methods of use thereof |
| JP7525499B2 (ja) | 2019-01-31 | 2024-07-30 | ヌマブ セラピューティクス アクチェンゲゼルシャフト | ＴＮＦα及びＩＬ－１７Ａに対する特異性を有する多重特異性抗体、ＩＬ－１７Ａを標的とする抗体、及びそれらの使用方法 |
| AU2020267504A1 (en) | 2019-05-08 | 2021-12-02 | Janssen Biotech, Inc. | Materials and methods for modulating T cell mediated immunity |
| CN116390950A (zh) | 2020-10-28 | 2023-07-04 | 詹森生物科技公司 | 用于调节δγ链介导的免疫的组合物和方法 |
| CN112646030B (zh) * | 2021-01-11 | 2021-11-30 | 内蒙古创润生物科技有限公司 | 一种包含间充质干细胞外泌体的药物组合物在治疗疾病中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050850A2 (en) * | 2002-12-02 | 2004-06-17 | Abgenix, Inc. | Antibodies directed to phospholipase a2 and uses thereof |
| GB0417487D0 (en) * | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| CN101326195B9 (zh) * | 2005-12-13 | 2022-11-11 | 伊莱利利公司 | 抗il-17抗体 |
| AU2007235199B8 (en) | 2006-01-31 | 2010-10-28 | Novartis Ag | IL-17 antagonistic antibodies for treating cancer |
| GB0612928D0 (en) * | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
| BRPI0715917A2 (pt) * | 2006-08-11 | 2014-11-25 | Schering Corp | Anticorpos para il-17a |
| BRPI0919531A2 (pt) | 2008-09-29 | 2015-12-08 | Roche Glycart Ag | anticorpos contra il17 humana e usos dos mesmos |
| US20120251552A1 (en) | 2009-11-05 | 2012-10-04 | Anaptysbio, Inc. | Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation |
-
2011
- 2011-08-02 JP JP2013523260A patent/JP2013537414A/ja active Pending
- 2011-08-02 US US13/814,262 patent/US9328166B2/en active Active
- 2011-08-02 EP EP11815158.8A patent/EP2601217B1/en active Active
- 2011-08-02 ES ES11815158.8T patent/ES2633145T3/es active Active
- 2011-08-02 NZ NZ60761511A patent/NZ607615A/en unknown
- 2011-08-02 AU AU2011285922A patent/AU2011285922B2/en active Active
- 2011-08-02 WO PCT/US2011/046201 patent/WO2012018767A2/en not_active Ceased
- 2011-08-02 BR BR112013002831A patent/BR112013002831A2/pt not_active Application Discontinuation
- 2011-08-02 CN CN201180048098.2A patent/CN103154026B/zh active Active
- 2011-08-02 RU RU2013109397/10A patent/RU2595385C2/ru active